Drug Type Stem cell therapy |
Synonyms Allogeneic granulocyte therapy LIfT BioSciences, NLIfT |
Target- |
Mechanism Cell replacements, Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization LIfT BioSciences Ltd.Startup |
Active Organization LIfT BioSciences Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | GB | LIfT BioSciences Ltd.Startup | 24 May 2024 |
Non-Small Cell Lung Cancer | Preclinical | GB | LIfT BioSciences Ltd.Startup | - |